Shared Content Block:
Styles -- modify testimonial colors
The mission of the RNA Bioscience Initiative (RBI) is to cultivate a vibrant center of discovery and innovation in RNA biology, informatics, diagnostics, and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
June 2, 2021
RBI Co-Director, David Bentley, PhD, was interviewed by 9News reporter Anusha Roy and featured on Next with Kyle Clark. In this piece Dr. Bentley expertly describes the future of mRNA technology and its possible therapeutic uses beyond the COVID vaccine.
May 5, 2021
Moderna recently announced that both its low-dose and variant-specific boosters effectively neutralize Covid-19 variants. Clinical trials of the boosters are ongoing; boosters are expected to be available in fall 2021.
RBI's Evan Morrison and his mentor, Olivia Rissland, have been selected as one of 50 new HHMI Gilliam student-advisor pairs. Gilliam fellowships are awarded to outstanding graduate students and their PhD mentors as part of a program to foster diversity and inclusion in biomedical or life science disciplines.
The NSF has awarded RBI's Dr. Olivia Rissand a prestigious Early Career Development award to study the maternal-to-zygotic transition in animal embryogenesis. The award will provide $1.3 million dollars of funding over five years.
RBI faculty members Matt Taliaferro, PhD and Chad Pearson, PhD, have been awarded a $1 million grant from the W.M. Keck Foundation for their project Control of cell division through centrosomal RNA localization. The goal of this study is to uncover the identity of centrosomal RNAs essential to the proper regulation of cell division. Given the links between centrosome dysfunction and cancer, it may reveal previously unidentified mechanisms that contribute to tumorigenesis.
Dr. Sujatha Jagannathan was recently awarded an investigator-initiated research grant by the FSHD Society. This grant will support her lab's work on identifying the mechanism by which the DUX4 inhibits nonsense-mediated RNA deco (NMD) in the human muscle disease facioscapulohumeral muscular dystrophy (FSHD). Congratulations Suja!
Congratulations to former RBI Scholar Brenna Dennison, whose manuscript has been featured in Development. Brenna was an RBI Scholar for the 2019-2020 year, and is currently a PhD student in Dr. Katherine Fantauzzo's lab.
Congratulations to Divya Kolakada, current RBI Scholar, for being awarded a Predoctoral Fellowship by the American Heart Society. Currently a PhD student in Dr. Sujatha Jagannathan's lab, Divya's project will be focused on investigating the fate of NMD substrates and their protein products.
Find out how Dr. Saldi leveraged her CU Anschutz-RBI training to advance her career. Currently she serves as the laboratory director of the COVID-19 Surveillance Lab at the BioFrontiers Institute and Chief Scientific Officer of TUMI Genomics, a diagnostics company she co-founded in 2020.
The RBI has made CU Anschutz a clear hub of RNA biology expertise, raising the status of the university and its researchers in the eyes of scientists at institutions around the country and the world. The RBI sets CU Anschutz up as a leader in the exciting and groundbreaking field of RNA biology.